SIGN UP
LOG IN
S
SGMO
Sangamo Therapeutics Inc
0.48
-0.02-3.96%Closed19:56 07/15 EDT
OPEN/PREV CLOSE0.4937/0.5000
TODAY RANGE0.4700-0.5079
VOL6.14M
MARKET CAP117.84M
52 WEEK RANGE0.3723-3.179
AVG VOL (3M)4.91M
% TURNOVER2.50%
TURNOVER--
P/E (TTM)-1.2522
% RANGE7.58%
EPS(TTM)-0.3835
P/E(FORWARD)-1.1599
P/B22.03
BVPS0.0218
DIVIDEND--
P/S1.768
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP114.55M
SHARES OUTSTANDING245.40M
NEXT EARNINGS08/04-08/08
FREE FLOAT238.55M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·06/25 11:36
Truist Financial Reaffirms Their Buy Rating on Sangamo Biosciences (SGMO)
TipRanks·06/24 16:35
Sangamo Biosciences (SGMO) Receives a Buy from H.C. Wainwright
Seeking Alpha·06/24 12:46
Sangamo rises after trial data for Fabry disease therapy
TipRanks·06/24 12:29
Sangamo Announces Positive Results for Fabry Disease Therapy
TipRanks·06/24 12:20
Sangamo announces topline results from STAAR study
TipRanks·06/16 20:32
Sangamo Biosciences Approves Amendments to Equity Plan
Barchart·06/11 14:43
RFK Jr. Just Supercharged These 2 Biotech Penny Stocks
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.